EN DE
STOCK COMPARISON

MARX Biotech Co. vs Jd Health International Inc: Fair Value & Quality

Both stocks run through our valuation models. Here is how MARX Biotech Co. (7731) and Jd Health International Inc (6618) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: MARX Biotech Co. trades at TWD 4.72 versus a fair value of TWD 1.40 (-70%), while Jd Health International Inc trades at HK$40.08 versus HK$33.28 (-17%).
MARX Biotech Co.
7731.TWO · TWD · Healthcare
-70%
upside to fair value
overvalued
PriceTWD 4.72
Fair ValueTWD 1.40
Quality31/100
Jd Health International Inc
6618.HK · HKD · Health Care
-17%
upside to fair value
overvalued
PriceHK$40.08
Fair ValueHK$33.28
Quality72/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

MARX Biotech Co.Jd Health International Inc
Valuation
62.8×P/E (TTM)17.6×
4.12×P/S (TTM)1.48×
7.29×P/B1.81×
—EV/EBITDA19.4×
—PEG1.26×
Profitability
7%Net margin7%
-33%Operating margin4%
14%Return on equity9%
-11%Return on assets3%
Growth
-19%Revenue growth (YoY)28%
79.1%Avg. growth/yr (3Y)16.3%
—Avg. growth/yr (5Y)30.5%
Balance & size
0.46×Debt / equity—
$81MMarket cap$14B
expensiveGrowth qualityhealthy

Jd Health International Inc leads: 2 to 7 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

MARX Biotech Co.of which business quality 34 · market factors 28 Jd Health International Incof which business quality 74 · market factors 22
ProfitabilityMargins and returns on capital today
53
47
Quality GrowthAre margins and returns improving?
27
80
CashflowEarnings quality: real cash, not paper profit
0
76
Fin. StrengthBalance sheet, leverage, solvency risk
58
100
InvestmentDisciplined investing over empire-building
33
66
Low VolatilityCalm price path (market factor)
45
42
MomentumPrice trend over the last 3–12 months (market factor)
21
12
52W MomentumDistance to the 52-week high (market factor)
19
18
Net IssuanceBuybacks instead of dilution
28
73

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

MARX Biotech Co.

DCF ModelsTWD 2.80
Earnings-BasedTWD 2.88
Dividend DiscountTWD 0.21
MultiplesTWD 1.40
Asset-BasedTWD 0.46
Economic ProfitTWD 0.74
Growth EarningsTWD 3.71

12 of 12 models see the stock below the current price.

Jd Health International Inc

DCF ModelsHK$70.32
Earnings-BasedHK$51.28
MultiplesHK$28.65
Asset-BasedHK$12.62
Growth DCFHK$77.68
Economic ProfitHK$20.89
Growth EarningsHK$70.00

10 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

MARX Biotech Co.
Bear TWD 1.05Fair Value TWD 1.40Bull TWD 1.99
TWD 4.72 = current price (white tick)
Jd Health International Inc
Bear HK$25.37Fair Value HK$33.28Bull HK$41.60
HK$40.08 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

MARX Biotech Co. · Healthcare

Quality score31 · bottom 25%
Fair value upside-70% · bottom 25%

Jd Health International Inc · Health Care

Quality score72 · Top 25%
Fair value upside-17% · above median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: MARX Biotech Co. trades at TWD 4.72 versus a fair value of TWD 1.40 (-70%), while Jd Health International Inc trades at HK$40.08 versus HK$33.28 (-17%).

Jd Health International Inc has the higher quality score (72/100).

See the full analysis →
MARX Biotech Co. · Jd Health International Inc

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to MARX Biotech Co.

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Jd Health International Inc

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.